Medlab Middle East 2024 Provides a Peek into the Laboratory of the Future
|
By LabMedica International staff writers Posted on 05 Feb 2024 |

Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress organized by Informa Markets, has returned to the Dubai World Trade Centre. Now in its 23rd year, Medlab Middle East features 900 exhibitors from more than 40 countries, up 20% from last year, and is being attended by more than 30,000 attendees. As the MENA region's most prominent medical laboratory exhibition and congress, Medlab Middle East plays a crucial role in developing the value of laboratory medicine in reshaping the future of diagnostics by providing a platform for laboratory industry leaders, including manufacturers, dealers, and distributors, to share best practice, showcase innovations, collaborate and network.
Medlab Middle East 2024 is exhibiting eight specialized product categories which include disposables, healthcare/general services, imaging, infrastructure, IT, laboratory, medical equipment and pharma/nutrition. Attendees can explore the latest laboratory technologies from every corner of the globe with dedicated country pavilions from China, Taiwan, Brazil, Finland, Poland, the USA, Spain, Korea, Italy, Egypt, and the UK. A key highlight of the 2024 edition of Medlab Middle East, taking place from 5-8 February, is the newly introduced ‘NextGen Medicine Zone and Conference, which is hosted in partnership with Express Med Diagnostics and Research (Manama, Bahrain). This innovative exhibition zone showcases over 100 exhibitors and brings into focus a pioneering area in the medical laboratory field that aims to customize healthcare to individuals, using advanced technologies and new developments in medical science.
The NextGen Medicine Conference, taking place from 5 to 6 February, explores topics such as early cancer detection, precision oncology, preventative health screening, longevity, developments in cancer genetics and oncogenomics as well as updates on Middle East genome projects. The conference also explores the digitalization aspects of NextGen Medicine which includes Artificial Intelligence (AI), bioinformatics, and the cybersecurity of data. Attendees can stay up to date with the latest insights and innovations in NextGen Medicine at expert-led industry workshops running from 5-7 February. Medlab Middle East Congress, the region’s only multi-disciplinary congress, has returned for another year. Offering 12 CME-accredited live in-person conferences throughout the four-day exhibition, the congress features over 130 speakers and 150 sessions, with over 4,000 delegates expected. NextGen Medicine and Clinical Genomic Interpretation are new additions to the Medlab Middle East congress this year, with returning tracks including Laboratory Management, Lab Quality Management, Clinical Chemistry, Immunology, Hematology, Clinical Microbiology, Blood Transfusion Medicine, Histopathology, Future of Lab and Sustainability in the Lab.
Additionally, innovation takes center stage at Labpreneur, Medlab Middle East’s annual start-up competition. Held on the last day of the exhibition, Labpreneur features 10 shortlisted start-ups that have created revolutionary concepts for the medical laboratory field. The winner of the competition is set to receive complimentary stand space for Medlab Middle East 2025 along with a prestigious award. Fostering the talents of future scientists, Medlab Middle East is hosting the second edition of LabQ, an inter-college quiz competition on pathology and laboratory medicine for senior graduating college and university students majoring in medical laboratory sciences in the UAE. The Scientific Poster Competition is returning this year, with the winner receiving a research grant of a value of up to USD 3,000. Elsewhere, attendees can expand their knowledge of the medical laboratory industry at the Medlab Partners Forum, which includes a think tank session from global research firm Frost & Sullivan and an insightful presentation from The Royal College of Pathologists on ‘The Global Challenge of Antimicrobial Resistance’.
“Medlab Middle East provides a unique platform for the laboratory industry to showcase innovative products, state-of-the-art services, and cutting-edge solutions in a central global hub,” said Tom Coleman, Exhibition Director for Informa Markets. “One of the most exciting features of this year's exhibition is the NextGen Medicine Zone and Conference, which promises to be a game-changer in the field. This groundbreaking zone will bring together experts from around the world who will share the latest scientific advancements, providing a unique opportunity for industry professionals to learn and explore new possibilities.”
Related Links:
Informa Markets
Express Med Diagnostics and Research
Latest Medlab 2024 News
- Anbio Biotechnology Presents Point-Of-Care IVD Solutions
- 77 Elektronika Showcases Latest Developments in Urinalysis
- BioVendor Group Unveils Latest Innovations in Immunodiagnostics and Molecular Diagnostics
- Sansure Presents Future of Pathogen Identification and Disease Diagnosis
- Spinreact Presents Latest Developments in IVD
- Alifax Demonstrates Automated Solutions to Improve Performance in Laboratory Settings
- YHLO Unveils New iBC 900 Automated Chemistry Analyzer
- Lifotronic Demonstrates Latest Medical Innovations in Disease Diagnostics
- Dymind Introduces New High-End Hematology Analyzer with Innovative Functions
- DIRUI Exhibits Latest Lab Automation Technologies and Devices
- Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer
- Boule Presents Next Generation Hematology and Clinical Chemistry Systems
- bioMérieux Showcases Advanced Generation of VIDAS Immunoassay Solution
- BioPerfectus Highlights Diagnostic Solutions for HPV & Cervical Cancer Screening, STIs and Vector-Borne Diseases
- Mindray Showcases Range of Advanced Total IVD Solutions
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








